Lubiprostone Capsule, Gelatin Coated
Product Images NDC 0254-3029

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 0254-3029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lubiprostone 01)

Chemical structure of lubiprostone, the active ingredient, showing its molecular connectivity including hydroxyl, carboxyl, and fluorinated alkyl groups.*

FDA Label Image

Principal Display Panel (8 mcg Capsule Bottle Label)

Lubiprostone Capsules 8 mcg gelatin coated capsules label for oral use by Par Pharmaceutical. The label indicates a 60 capsule count, Rx only, with storage instructions and handling information. The label includes the NDC code 0254-3028-02 and manufacturing details.*

FDA Label Image

Principal Display Panel (24 mcg Capsule Bottle Label)

Lubiprostone Capsules 24 mcg gelatin coated oral capsules label showing 60 capsules per container. Manufactured by Par Pharmaceutical in Chestnut Ridge, NY, with instructions to swallow whole and store between 15-30°C. Active ingredient made in Japan and encapsulated in the U.S. Instructions include keeping out of reach of children and dispensing in a tightly closed, light-resistant container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.